Want to see IN:WINDLAS full AI Analyst Report?
Total Valuation
Windlas Biotech Ltd. has a market cap or net worth of ₹22.75B. The enterprise value is ₹13.31K.
Market Cap₹22.75B
Enterprise Value₹13.31K
Share Statistics
Windlas Biotech Ltd. has 20,636,229 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,636,229
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Windlas Biotech Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.13%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.13%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee6.53M
Profits Per Employee479.83K
Employee Count1,385
Asset Turnover1.00
Inventory Turnover11.97
Valuation Ratios
The current PE Ratio of Windlas Biotech Ltd. is 34.0. Windlas Biotech Ltd.’s PEG ratio is 2.80.
PE Ratio34.0
PS Ratio1.71
PB Ratio2.67
Price to Fair Value2.67
Price to FCF45.88
Price to Operating Cash Flow40.36
PEG Ratio2.80
Income Statement
In the last 12 months, Windlas Biotech Ltd. had revenue of 9.04B and earned 664.56M in profits. Earnings per share was 31.60.
Revenue9.04B
Gross Profit1.64B
Operating Income739.99M
Pretax Income869.77M
Net Income664.56M
EBITDA1.05B
Earnings Per Share (EPS)31.60
Cash Flow
In the last 12 months, operating cash flow was 559.24M and capital expenditures -293.90M, giving a free cash flow of 265.34M billion.
Operating Cash Flow559.24M
Free Cash Flow265.34M
Free Cash Flow per Share12.86
Dividends & Yields
Windlas Biotech Ltd. pays an annual dividend of ₹6.3, resulting in a dividend yield of 0.58%
Dividend Per Share₹6.3
Dividend Yield0.58%
Payout Ratio19.85%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change18.98%
50-Day Moving Average976.70
200-Day Moving Average841.90
Relative Strength Index (RSI)56.50
Average Volume (3m)8.25K
Important Dates
Windlas Biotech Ltd. upcoming earnings date is Nov 14, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 14, 2026
Ex-Dividend Date―
Financial Position
Windlas Biotech Ltd. as a current ratio of 1.95, with Debt / Equity ratio of 0.00%
Current Ratio1.95
Quick Ratio1.76
Debt to Market Cap0.02
Net Debt to EBITDA0.32
Interest Coverage Ratio15.33
Taxes
In the past 12 months, Windlas Biotech Ltd. has paid 205.21M in taxes.
Income Tax205.21M
Effective Tax Rate0.24
Enterprise Valuation
Windlas Biotech Ltd. EV to EBITDA ratio is 15.11, with an EV/FCF ratio of 46.87.
EV to Sales1.75
EV to EBITDA15.11
EV to Free Cash Flow46.87
EV to Operating Cash Flow15.60
Balance Sheet
Windlas Biotech Ltd. has ₹2.79B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹2.79B billion.
Cash & Marketable Securities₹2.79B
Total Debt₹0.00
Net Cash₹2.79B
Net Cash Per Share₹135.11
Tangible Book Value Per Share₹272.91
Margins
Gross margin is 22.41%, with operating margin of 8.18%, and net profit margin of 7.35%.
Gross Margin22.41%
Operating Margin8.18%
Pretax Margin9.62%
Net Profit Margin7.35%
EBITDA Margin11.59%
EBIT Margin8.18%
Analyst Forecast
The average price target for Windlas Biotech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.53%
EPS Growth Forecast1.89%